Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dogwood Therapeutics Inc (DWTX)

Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dogwood Therapeutics Inc 44 MILTON AVENUE ALPHARETTA GA 30009 USA

www.dwtx.com Employees: 12 P: 866-620-8655

Sector:

Medical

Description:

Dogwood Therapeutics Inc. is a biopharmaceutical company. It engages in developing a new class of non-opioid analgesics. The company focuses on the development of Halneuron, IMC-1 and IMC-2. Dogwood Therapeutics Inc., formerly known as Virios Therapeutics Inc., is based in Alpharetta, GA.

Key Statistics

Overview:

Market Capitalization, $K 15,640
Enterprise Value, $K 90,580
Shares Outstanding, K 2,293
Annual Sales, $ 0 K
Annual Net Income, $ -12,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -15,740 K
EBIT, $ -31,700 K
EBITDA, $ -31,630 K
60-Month Beta 1.86
% of Insider Shareholders 3.60%
% of Institutional Shareholders 9.05%
Float, K 2,211
% Float 96.40%
Short Volume Ratio 0.43

Growth:

1-Year Return 182.99%
3-Year Return 10.22%
5-Year Return -97.38%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -8.20 on 11/06/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -20.69
EPS Growth vs. Prev Qtr -312.06%
EPS Growth vs. Prev Year -300.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/09/24

DWTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -35.11%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 33.79
Interest Coverage -0.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar